TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/24 17:04 | 7/10/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Duker Jay S. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 17 | 38 | 61 | D | ||||||||||||||
2/13/24 17:37 | 2/9/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Duker Jay S. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 12 | 30 | 52 | D | ||||||||||||||
1/9/24 21:07 | 1/6/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Duker Jay S. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 21 | 92 | 43 | D | ||||||||||||||
2/13/23 17:03 | 2/9/23 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Duker Jay S. | MA | O | P,COO | M.d | 0 | 0.00 | 0 | 12 | 69 | 29 | D | ||||||||||||||
11/3/22 08:38 | 11/1/22 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Duker Jay S. | MA | O | COO | M.d | 0 | 0.00 | 0 | 15 | 248 | 21 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |